Search / Trial NCT06230432

Exploring the Mechanism of Severe Acute Pancreatitis Based on Metagenomics, Metabolomics and Proteomics

Launched by THE FIRST AFFILIATED HOSPITAL OF NANCHANG UNIVERSITY · Jan 20, 2024

Trial Information

Current as of October 07, 2024

Not yet recruiting

Keywords

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients group:
  • ① Age between 18 and 75 years old;
  • ② Within 72 hours of AP onset;
  • ③ AP patients who meet the 2012 Atlanta AP Classification and Diagnostic Criteria.
  • Healthy control group:
  • * Age between 18 and 75 years old; ② No history of acute pancreatitis; ③ Routine laboratory tests such as blood routine and fecal routine are normal.
  • Exclusion Criteria:
  • * Used antibiotics, probiotics, and acid suppressants 4 weeks before enrollment;
  • * Pregnant and lactating women;
  • * Hypothyroidism, nephrotic syndrome, Cushing's syndrome, AIDS;
  • * Chronic pancreatitis, pancreatic cancer; ⑤ Severe history of cardiovascular and cerebrovascular diseases and organ dysfunction, such as malignant tumors, heart failure, coronary heart disease, chronic obstructive pulmonary disease, liver and kidney failure; ⑥ Unsigned informed consent form.

About The First Affiliated Hospital Of Nanchang University

The First Affiliated Hospital of Nanchang University is a leading medical institution dedicated to advancing healthcare through innovative clinical research and high-quality patient care. As a prominent teaching hospital, it plays a pivotal role in medical education and training, fostering a collaborative environment for healthcare professionals. With a commitment to excellence, the hospital conducts a wide range of clinical trials aimed at improving treatment outcomes and enhancing patient safety. Its state-of-the-art facilities and multidisciplinary expertise position it as a key player in the advancement of medical science and the development of new therapeutic solutions.

Locations

Nanchang, Jiangxi, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0